Resources for Researchers
Phase I Clinical Trial Units for Therapeutics
About
What services does this resource provide?
The Phase I Clinical Trial Units for Therapeutics will assess the safety of therapeutic products (excluding biologics) within the scope of viral (other than HIV), bacterial, parasitic, and fungal pathogens, including NIAID priority bio-defense pathogens and emerging and re-emerging infectious diseases.
Where are services provided?
Services are provided by:
- DynPort Vaccine Company with a clinical site at the Quintiles Phase I Unit in Overland Park, Kansas.
- Clinical Research Management with clinical sites at Johns Hopkins University in Baltimore, Maryland, and Case Western Reserve University in Cleveland, Ohio.
Access
